LULULEMON ATHLETICA INC (33L.DE) Fundamental Analysis & Valuation

FRA:33L • US5500211090

148.38 EUR
+0.56 (+0.38%)
Last: Mar 4, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This 33L.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Taking everything into account, 33L scores 7 out of 10 in our fundamental rating. 33L was compared to 45 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the health and profitability get an excellent rating, making 33L a very profitable company, without any liquidiy or solvency issues. 33L has a decent growth rate and is not valued too expensively. These ratings would make 33L suitable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. 33L.DE Profitability Analysis

1.1 Basic Checks

  • 33L had positive earnings in the past year.
  • 33L had a positive operating cash flow in the past year.
  • 33L had positive earnings in each of the past 5 years.
  • 33L had a positive operating cash flow in each of the past 5 years.
33L.DE Yearly Net Income VS EBIT VS OCF VS FCF33L.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

  • 33L has a Return On Assets of 21.88%. This is amongst the best in the industry. 33L outperforms 97.78% of its industry peers.
  • 33L's Return On Equity of 38.67% is amongst the best of the industry. 33L outperforms 91.11% of its industry peers.
  • With an excellent Return On Invested Capital value of 28.30%, 33L belongs to the best of the industry, outperforming 95.56% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for 33L is significantly above the industry average of 12.24%.
Industry RankSector Rank
ROA 21.88%
ROE 38.67%
ROIC 28.3%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
33L.DE Yearly ROA, ROE, ROIC33L.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • 33L has a Profit Margin of 15.72%. This is amongst the best in the industry. 33L outperforms 82.22% of its industry peers.
  • In the last couple of years the Profit Margin of 33L has remained more or less at the same level.
  • With an excellent Operating Margin value of 22.05%, 33L belongs to the best of the industry, outperforming 84.44% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 33L has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 58.41%, 33L is in line with its industry, outperforming 42.22% of the companies in the same industry.
  • 33L's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.05%
PM (TTM) 15.72%
GM 58.41%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
33L.DE Yearly Profit, Operating, Gross Margins33L.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. 33L.DE Health Analysis

2.1 Basic Checks

  • 33L has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for 33L has been reduced compared to 1 year ago.
  • Compared to 5 years ago, 33L has less shares outstanding
  • 33L has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
33L.DE Yearly Shares Outstanding33L.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
33L.DE Yearly Total Debt VS Total Assets33L.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 6.98 indicates that 33L is not in any danger for bankruptcy at the moment.
  • 33L has a Altman-Z score of 6.98. This is amongst the best in the industry. 33L outperforms 91.11% of its industry peers.
  • 33L has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.98
ROIC/WACC2.78
WACC10.18%
33L.DE Yearly LT Debt VS Equity VS FCF33L.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • 33L has a Current Ratio of 2.13. This indicates that 33L is financially healthy and has no problem in meeting its short term obligations.
  • 33L has a better Current ratio (2.13) than 77.78% of its industry peers.
  • 33L has a Quick Ratio of 1.05. This is a normal value and indicates that 33L is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.05, 33L is doing good in the industry, outperforming 68.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.05
33L.DE Yearly Current Assets VS Current Liabilites33L.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. 33L.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.19% over the past year.
  • Measured over the past years, 33L shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.37% on average per year.
  • 33L shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.76%.
  • The Revenue has been growing by 21.62% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)4.19%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%-9.76%
Revenue 1Y (TTM)8.76%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%7.06%

3.2 Future

  • Based on estimates for the next years, 33L will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.56% on average per year.
  • 33L is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.73% yearly.
EPS Next Y-9.02%
EPS Next 2Y-6.35%
EPS Next 3Y-1.34%
EPS Next 5Y8.56%
Revenue Next Year4.66%
Revenue Next 2Y4.56%
Revenue Next 3Y4.82%
Revenue Next 5Y6.73%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
33L.DE Yearly Revenue VS Estimates33L.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
33L.DE Yearly EPS VS Estimates33L.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

5

4. 33L.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • 33L is valuated reasonably with a Price/Earnings ratio of 11.98.
  • Compared to the rest of the industry, the Price/Earnings ratio of 33L indicates a rather cheap valuation: 33L is cheaper than 86.67% of the companies listed in the same industry.
  • 33L is valuated cheaply when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 13.41, which indicates a correct valuation of 33L.
  • 33L's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 33L is cheaper than 75.56% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.11, 33L is valued a bit cheaper.
Industry RankSector Rank
PE 11.98
Fwd PE 13.41
33L.DE Price Earnings VS Forward Price Earnings33L.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 33L is valued a bit cheaper than 75.56% of the companies in the same industry.
  • 33L's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 17.97
EV/EBITDA 6.55
33L.DE Per share data33L.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The excellent profitability rating of 33L may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.49
EPS Next 2Y-6.35%
EPS Next 3Y-1.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 33L.DE Dividend Analysis

5.1 Amount

  • 33L does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

33L.DE Fundamentals: All Metrics, Ratios and Statistics

LULULEMON ATHLETICA INC

FRA:33L (3/4/2026, 7:00:00 PM)

148.38

+0.56 (+0.38%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)12-11
Earnings (Next)06-03
Inst Owners81.14%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap17.41B
Revenue(TTM)11.07B
Net Income(TTM)1.74B
Analysts66
Price Target180.74 (21.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.12%
Min EPS beat(2)5.62%
Max EPS beat(2)12.63%
EPS beat(4)3
Avg EPS beat(4)4.95%
Min EPS beat(4)-1.37%
Max EPS beat(4)12.63%
EPS beat(8)7
Avg EPS beat(8)4.76%
EPS beat(12)11
Avg EPS beat(12)5.37%
EPS beat(16)14
Avg EPS beat(16)5.09%
Revenue beat(2)1
Avg Revenue beat(2)-0.7%
Min Revenue beat(2)-2.5%
Max Revenue beat(2)1.1%
Revenue beat(4)1
Avg Revenue beat(4)-0.94%
Min Revenue beat(4)-2.5%
Max Revenue beat(4)1.1%
Revenue beat(8)1
Avg Revenue beat(8)-1.3%
Revenue beat(12)3
Avg Revenue beat(12)-0.78%
Revenue beat(16)6
Avg Revenue beat(16)-0.29%
PT rev (1m)-6.5%
PT rev (3m)1.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.98%
EPS NY rev (1m)0.03%
EPS NY rev (3m)1.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.08%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.71%
Valuation
Industry RankSector Rank
PE 11.98
Fwd PE 13.41
P/S 1.83
P/FCF 17.97
P/OCF 10.9
P/B 4.5
P/tB 4.69
EV/EBITDA 6.55
EPS(TTM)12.39
EY8.35%
EPS(NY)11.07
Fwd EY7.46%
FCF(TTM)8.26
FCFY5.57%
OCF(TTM)13.62
OCFY9.18%
SpS81.03
BVpS32.94
TBVpS31.61
PEG (NY)N/A
PEG (5Y)0.49
Graham Number95.83
Profitability
Industry RankSector Rank
ROA 21.88%
ROE 38.67%
ROCE 39.94%
ROIC 28.3%
ROICexc 34.07%
ROICexgc 35.34%
OM 22.05%
PM (TTM) 15.72%
GM 58.41%
FCFM 10.19%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
ROICexc(3y)45.65%
ROICexc(5y)41.54%
ROICexgc(3y)46.74%
ROICexgc(5y)45.9%
ROCE(3y)41.97%
ROCE(5y)38.1%
ROICexgc growth 3Y-2.73%
ROICexgc growth 5Y3.8%
ROICexc growth 3Y3.22%
ROICexc growth 5Y3.16%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
F-Score6
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 147.91%
Cap/Sales 6.62%
Interest Coverage 250
Cash Conversion 63.37%
Profit Quality 64.82%
Current Ratio 2.13
Quick Ratio 1.05
Altman-Z 6.98
F-Score6
WACC10.18%
ROIC/WACC2.78
Cap/Depr(3y)181.68%
Cap/Depr(5y)168.92%
Cap/Sales(3y)7.05%
Cap/Sales(5y)6.53%
Profit Quality(3y)77.23%
Profit Quality(5y)86.23%
High Growth Momentum
Growth
EPS 1Y (TTM)4.19%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%-9.76%
EPS Next Y-9.02%
EPS Next 2Y-6.35%
EPS Next 3Y-1.34%
EPS Next 5Y8.56%
Revenue 1Y (TTM)8.76%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%7.06%
Revenue Next Year4.66%
Revenue Next 2Y4.56%
Revenue Next 3Y4.82%
Revenue Next 5Y6.73%
EBIT growth 1Y2.59%
EBIT growth 3Y22.21%
EBIT growth 5Y23.02%
EBIT Next Year9.23%
EBIT Next 3Y4.1%
EBIT Next 5Y9.29%
FCF growth 1Y-13.6%
FCF growth 3Y16.77%
FCF growth 5Y32.6%
OCF growth 1Y-4.97%
OCF growth 3Y17.83%
OCF growth 5Y27.7%

LULULEMON ATHLETICA INC / 33L.DE FAQ

What is the ChartMill fundamental rating of LULULEMON ATHLETICA INC (33L.DE) stock?

ChartMill assigns a fundamental rating of 7 / 10 to 33L.DE.


What is the valuation status of LULULEMON ATHLETICA INC (33L.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to LULULEMON ATHLETICA INC (33L.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for LULULEMON ATHLETICA INC?

LULULEMON ATHLETICA INC (33L.DE) has a profitability rating of 8 / 10.


What is the financial health of LULULEMON ATHLETICA INC (33L.DE) stock?

The financial health rating of LULULEMON ATHLETICA INC (33L.DE) is 9 / 10.


Can you provide the expected EPS growth for 33L stock?

The Earnings per Share (EPS) of LULULEMON ATHLETICA INC (33L.DE) is expected to decline by -9.02% in the next year.